Risk for fungal infections doubles with corticosteroid use vs. TNF-a inhibitors in IBD

SAN DIEGO — Corticosteroid use should be minimized in patients with inflammatory bowel disease to reduce the risk for invasive fungal infections, according to research presented at Digestive Disease Week 2022.“We know that the immunosuppressants used to treat IBD increase the risk for infection and multiple studies have shown that corticosteroids are by far the worst agents,” Martin H. Gregory, MD, of the division of gastroenterology at Washington University School of Medicine in St. Louis, said. “There hasn’t been a large scale, systematic study to see what riskRead More